Related Experiment Videos
Retrolental fibroplasia: a medical dilemma
Journal of the American Optometric Association
|July 1, 1982
Insights
Retrolental fibroplasia (RLF) is a major cause of infant visual impairment. This review covers RLF pathophysiology, risk factors, diagnosis, and treatment strategies for affected infants.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatrics
Background:
- Retrolental fibroplasia (RLF) is a significant cause of vision loss in infants.
- Understanding RLF's pathophysiology and risk factors is crucial for prevention and early intervention.
Purpose of the Study:
- To provide a comprehensive overview of Retrolental fibroplasia (RLF).
- To discuss the pathophysiology, risk factors, clinical presentation, and management of RLF.
Main Methods:
- Literature review of Retrolental fibroplasia (RLF).
- Discussion of established knowledge regarding RLF pathophysiology and clinical course.
Main Results:
- RLF pathophysiology involves complex interactions, with prematurity and oxygen exposure being key risk factors.
- The clinical course presents in distinct stages, necessitating careful differential diagnosis.
Conclusions:
- Effective management of RLF requires early detection and tailored treatment strategies.
- Continued research into RLF pathogenesis and prevention is essential for improving infant visual outcomes.
Abstract:
Retrolental fibroplasia (RLF) remains as a leading cause of visual impairment in infants. The pathophysiology of RLF is discussed as well as the significant risk factors. The clinical course of the disease is considered including the various stages of RLF and the differential diagnosis. Finally, the management and treatment options of RLF are discussed.